Marcus Wolf Nikos Research is a boutique investment research firm that consistently delivers insights and profitable investment recommendations to its subscribers.

​

For too long, the best investment research has not been available to individual investors. It has been typically reserved for investment banks, hedge funds, private equity, and high-net-worth clients.

 

The mission of Marcus Wolf Nikos Research is to make that kind of proprietary research available to any investors looking to gain an edge in the markets. The goal is simple… to deliver unique and profitable investment research found nowhere else.

 

Marcus Wolf Nikos Research publishes one of the most widely read Bio technology e-letters in the world, The Bio-Tech Network , which delivers daily insights and information from the Bio -tech world as well as topics and trends relevant to investments.

 

Marcus Wolf Nikos flagship investment newsletter, The Vision Report, is focused on large-capitalization Bio technology companies that are still in growth mode and deliver outsized returns. Its model portfolio consistently outperforms the markets year after year.

 

Additionally, Marcus Wolf Nikos Research publishes highly specialized, alpha-driven investment research in The Compound Effect , Early Stage Trader,Blank Check SMastery , Outlier Investor, and Renaissance Profits. Nikos Unlimited focuses on small- and micro-capitalizationBio technology companies on the bleeding edge, whereas Early Stage Trader focuses primarily on early stage, pre-revenue biotechnology companies developing novel approaches to curing human disease. Blank Check Mastery specializes in finding the most exciting investments from the world of special purpose acquisition corporations (SPACs).

 

Outlier Investor is a service using expert stock-picker Christian Wolf proprietary data-driven system to determine when big financial institutions are likely buying specific growth stocks. And finally, Renaissance Profits shares cutting-edge research on exciting opportunities within the developing blockchain and cryptocurrency space.

 

Marcus Wolf Nikos Research’s Founder and Chief Investment Analyst Marcus Wolf Nikos is a Bio technology mastermind with nearly 30 years of experience.

​

And as an active angel investor, Nikos has seen firsthand the wealth-creating potential of disruptive Bio technology.

Today, Nikos uses his Bio technology, finance, and investing expertise to help everyday investors pinpoint companies on the verge of exponential growth.